The Award: Up to $50,000 in grant support for a period of up to 12 months, as well as mentoring and project management support.

Eligibility: Faculty in all series and ranks at UC Davis, UC Irvine, UCLA, UC San Diego, and UC San Francisco are eligible. Postdoctoral scholars, project scientists, and staff researchers are not eligible to serve as principal investigator of a UC DDC seed award unless they have been granted principal investigator status on their campus. Researchers who are UC scientists but not faculty can be listed as co-principal investigators.

Requirements: Projects should have have existing or imminent target validation in animal systems or human cell lines and a clear clinical indication. All therapeutic areas where there is an unmet medical need or the potential for significant improvement over current treatments are acceptable.

Selection Process and Review: Applicants will first submit a Letter of Intent (LOI) to their respective campus contacts, who will select up to three proposals from each campus to go forward as full applications. All full applications will be reviewed by a committee consisting of all representatives from the MRPI grant campuses, along with disease and platform experts from academia and industry who will be under a non-disclosure confidentiality agreement. A maximum of six projects will be funded in this cycle.